GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $6,384 | $0 | $962 | $3,001 |
| % Growth | – | -100% | -67.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $6,384 | $0 | $962 | $3,001 |
| % Margin | 100% | – | 100% | 100% |
| R&D Expenses | $133,810 | $89,832 | $42,866 | $23,489 |
| G&A Expenses | $35,930 | $20,321 | $11,165 | $8,714 |
| SG&A Expenses | $35,930 | $20,321 | $11,165 | $8,714 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$396 | -$1,595 | -$785 | $0 |
| Operating Expenses | $169,344 | $108,558 | $53,246 | $32,203 |
| Operating Income | -$163,919 | -$108,558 | -$52,284 | -$29,202 |
| % Margin | -2,567.7% | – | -5,434.9% | -973.1% |
| Other Income/Exp. Net | -$2,044 | -$3,752 | -$967 | $553 |
| Pre-Tax Income | -$165,963 | -$112,310 | -$53,251 | -$28,649 |
| Tax Expense | $1,092 | $2,419 | $1,028 | $317 |
| Net Income | -$167,055 | -$114,729 | -$54,279 | -$28,966 |
| % Margin | -2,616.8% | – | -5,642.3% | -965.2% |
| EPS | -1.27 | -0.93 | -0.56 | -0.3 |
| % Growth | -36.6% | -66.1% | -86.7% | – |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.3 |
| Weighted Avg Shares Out | 131,976 | 122,822 | 96,351 | 96,351 |
| Weighted Avg Shares Out Dil | 131,976 | 122,822 | 96,351 | 96,351 |
| Supplemental Information | – | – | – | – |
| Interest Income | $895 | $37 | $83 | $865 |
| Interest Expense | $4,123 | $2,419 | $1,028 | $317 |
| Depreciation & Amortization | $9,930 | $5,809 | $1,837 | $1,553 |
| EBITDA | -$153,989 | -$102,749 | -$50,447 | -$27,649 |
| % Margin | -2,412.1% | – | -5,244% | -921.3% |